Johnson & Johnson (JNJ) Q4 2024 Earnings Breakdown cover art

Johnson & Johnson (JNJ) Q4 2024 Earnings Breakdown

Johnson & Johnson (JNJ) Q4 2024 Earnings Breakdown

Listen for free

View show details

About this listen

Key Highlights:

  • Overall Growth: Worldwide sales increased by 5.3% in 4Q24 and 4.3% for the full year. However, when excluding currency impacts, operational growth reached 6.7% for 4Q24 and 5.9% for the full year, showing the strength of underlying business performance.
  • "Worldwide 22,520$ 21,395 5.3 % 6.7 (1.4) 88,821$ 85,159 4.3 % 5.9 (1.6)"
  • U.S. Strength: The U.S. market demonstrated robust growth, with a 10.0% sales increase in both 4Q24 and the full year.
  • "U.S. 13,204$ 12,009 10.0 % 10.0 - 50,302$ 46,444 8.3 % 8.3 -"
  • International Headwinds: International sales were negatively impacted by currency fluctuations and saw lower operational growth. Sales declined slightly by 0.7% in 4Q24, but with currency impacts removed, operational growth was 2.5%. For the full year, international sales decreased by 0.5%, with 2.9% operational growth.
  • "International 9,316 9,386 (0.7) 2.5 (3.2) 38,519 38,715 (0.5) 2.9 (3.4)"
  • COVID-19 Vaccine Impact: Sales from the COVID-19 vaccine are now negligible and have a limited impact on the current reporting. The analysis focuses on performance excluding these sales to reflect core business strength.
  • "Worldwide excluding COVID-19 Vaccine (1) 22,520$ 21,351 5.5 % 6.9 (1.4) 88,623$ 84,042 5.5 % 7.0 (1.5)"

What listeners say about Johnson & Johnson (JNJ) Q4 2024 Earnings Breakdown

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.